Taiwan Liposome Company, Ltd. TLC
7.00 0.00 (+0.00%)
Apr 24, 2025, 3:47 PM EDT
7.00 Day range 7.09
52-week range unavailable
Analyst view
Consensus: buy
Buy
Price target (mean) 9.25 +32.1% upside
Now 7.00
- Target (low)
- 7.50
- Target (mean)
- 9.25
- Target (high)
- 11.00
Ratings (0m) 3 3 buy · 0 hold · 0 sell
- Strong buy1
- Buy2
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 3
- 1 month ago 3
- 2 months ago 3
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.07 | -0.07 – -0.07 | -0.10 | +30.0% | 5.00M | +119.0% | 1 |
| Next quarter | -0.07 | -0.07 – -0.07 | -0.26 | +73.1% | 5.00M | +850.6% | 1 |
| Current year | -0.35 | -0.35 – -0.35 | -0.88 | +60.2% | 17.10M | +371.1% | 1 |
| Next year | -0.48 | -0.48 – -0.48 | -0.35 | -37.1% | 8.00M | -53.2% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jul 13, 2021 | HC Wainwright & Co. | Downgrade | Buy | Neutral |
| Jun 1, 2020 | Cantor Fitzgerald | Maintained | — | Overweight |
| Feb 12, 2020 | Cantor Fitzgerald | Reiterated | — | Overweight |
| Dec 23, 2019 | Cantor Fitzgerald | Initiated | — | Overweight |
| Jun 21, 2019 | Baird | Initiated | — | Outperform |
| Dec 17, 2018 | Laidlaw & Co. | Initiated | — | Buy |
| Dec 17, 2018 | H.C. Wainwright | Initiated | — | Buy |